Articles related to CONTRACEPTION/BIRTH CONTROL

Recent findings presented at the ASA’s annual meeting spotlight the critical role of tranexamic acid in postpartum hemorrhage, underscoring a dose-response relationship that enhances antifibrinolysis, marking a significant advancement in obstetric care.

This study offers valuable insights into the safety of stimulant medication use during pregnancy, highlighting the need for nuanced patient counseling and consideration of individual risks and benefits in managing ADHD symptoms.

In facing her own miscarriage, a physician reflects on the absence of trauma-informed care and resilience training in her medical education, underscoring the necessity of integrating these components to better support healthcare professionals in their dual roles as caregivers and individuals.

Physicians should be aware that sexual dysfunction encompasses a broad range of factors, including psychological and physical conditions, and is not solely a hormonal issue. Understanding this complexity is key in patient treatment.

Zurzuvae represents a novel approach in postpartum depression therapy, with clinical trials revealing substantial symptom reduction within the initial treatment period. This advancement offers a new horizon in PPD management for healthcare professionals.

Peripartum cardiomyopathy presents a unique challenge in maternal health, with its late pregnancy symptoms often leading to delayed diagnosis. Understanding its hormonal and genetic underpinnings is vital for effective management.